A 70-year-old woman can absolutely have endometriosis. While the condition is overwhelmingly associated with reproductive-age women, a growing body of research confirms that endometriosis persists, reactivates, or even appears for the first time well after menopause. The old assumption that menopause “cures” endometriosis has been challenged in recent years, though research on the postmenopausal form remains thin and much about it is still poorly understood.
Why Endometriosis Was Long Considered a Younger Woman’s Disease
Endometriosis involves tissue resembling the uterine lining growing outside the uterus, typically on the ovaries, fallopian tubes, or pelvic lining. Because this tissue responds to estrogen, and estrogen levels drop sharply at menopause, the prevailing view for decades was that the disease would simply burn itself out once a woman’s ovaries stopped producing significant amounts of the hormone. For many women, symptoms do improve or resolve after menopause. But “usually improves” and “always disappears” are very different claims, and the latter was never true.
The shift in thinking has been slow. Literature on postmenopausal endometriosis remains limited, with uncertainties around how common the condition really is, how best to manage it, and what its long-term outlook looks like.1Maturitas. Menopause and endometriosis Much of what we know comes from case reports and small case series rather than large-scale studies, which makes it difficult to give a woman in her 60s or 70s a confident prognosis based on the existing data alone.2PubMed Central. Endometriosis in Menopause-Renewed Attention on a Controversial Disease
How Endometriosis Survives Without Ovarian Estrogen
The key to understanding endometriosis in a 70-year-old lies in where estrogen comes from after the ovaries retire. The ovaries are the major source during reproductive years, but they are not the only source. Fat tissue, the adrenal glands, and the endometriotic implants themselves can all produce estrogen in smaller amounts. That last point is especially important.
Endometriotic tissue has been shown to contain an enzyme called aromatase at much higher levels than normal uterine lining. Aromatase converts other hormones into estrogen locally, right at the site of the implant, creating a self-sustaining loop. The locally produced estrogen stimulates the tissue to produce inflammatory compounds, which in turn spur even more aromatase activity.3PubMed. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis Normal endometrium in disease-free women does not express aromatase in meaningful amounts, but endometriotic implants do, sometimes in far larger quantities than the lining tissue still inside the uterus.4PubMed Central. Local estrogen formation and its regulation in endometriosis
This means a postmenopausal woman does not need high circulating estrogen for endometriosis to remain active. The implants can effectively fuel themselves. It also helps explain why body weight matters: fat tissue is the main non-ovarian source of estrogen after menopause, so women with higher body fat may have more circulating estrogen available to feed surviving implants.
Reactivation Versus Brand-New Disease
Researchers still debate whether postmenopausal endometriosis is old disease waking up or new disease forming from scratch. Both scenarios appear to occur. Some women had endometriosis diagnosed years or decades earlier, saw their symptoms fade at menopause, and then experienced a flare-up. Others seem to develop endometriotic lesions for the first time after menopause, with no documented history of the condition during their reproductive years.5PubMed. Postmenopausal Endometriosis: Clinical Insights and Imaging Considerations6Sri Lanka Journal of Menopause. Postmenopausal Endometriosis
De novo cases are particularly puzzling, since the conventional theory of retrograde menstruation (menstrual blood flowing backward through the fallopian tubes and seeding the pelvis) obviously cannot apply to someone who has not menstruated in twenty years. Theories for these late-onset cases include transformation of other cell types in the peritoneum into endometrial-like tissue, as well as possible roles for stem cells or immune dysfunction. None of these explanations are firmly established, and the honest answer is that the mechanism behind genuinely new postmenopausal endometriosis remains unclear.
What Symptoms Look Like After Menopause
The classic symptoms of endometriosis in younger women, especially painful periods and pain during sex, do not translate neatly to a 70-year-old. Postmenopausal women with endometriosis may instead experience pelvic pain that has no obvious hormonal cycle behind it, pain during bowel movements, or urinary symptoms. Some women have no symptoms at all, and the endometriosis is found incidentally during imaging or surgery performed for another reason.7PubMed. Endometriosis in the postmenopausal female: clinical presentation, imaging features, and management
Pain can appear at any stage of life in women with endometriosis, and the lack of specificity in symptoms makes the condition easy to miss in older patients.1Maturitas. Menopause and endometriosis When pain or a pelvic mass does develop in a postmenopausal woman, clinicians are more likely to think first of cancer, irritable bowel syndrome, diverticular disease, or adhesions from prior surgeries. Endometriosis may not even appear on the list of possibilities, especially if the woman has no known history of the disease.
Research also suggests that endometriosis during reproductive years can cast a long shadow. Women who had endometriosis before menopause showed clear links between how much their disease limited them physically and socially during their younger years and their likelihood of experiencing ongoing pain and sexual difficulties after menopause.8PubMed Central. Endometriosis patients in the postmenopausal period: pre- and postmenopausal factors influencing postmenopausal health The disease may leave its mark even when the tissue itself has gone quiet.
Hormone Therapy and Tamoxifen as Triggers
The most clearly identified risk factor for postmenopausal endometriosis is external hormone exposure. Hormone replacement therapy, prescribed to manage hot flashes, bone loss, and other menopausal symptoms, can reactivate dormant endometriotic implants by restoring estrogen levels. Postmenopausal endometriosis is more common in women taking HRT, and the type of hormone preparation matters.5PubMed. Postmenopausal Endometriosis: Clinical Insights and Imaging Considerations
Estrogen-only HRT carries a higher risk of reactivation than combined preparations that include a progestogen, particularly in women who previously had severe endometriosis or who are obese.9PubMed. Hormone replacement therapy in women with past history of endometriosis For women with a known history of endometriosis who need HRT, continuous combined preparations or tibolone appear to be safer choices, though the evidence base supporting these recommendations is not strong.10PubMed Central. Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature The majority of reported reactivation cases have occurred in women who had undergone hysterectomy and were receiving estrogen without progestogen opposition.
Tamoxifen, widely used as adjuvant therapy for breast cancer, presents a separate risk. Though it blocks estrogen in breast tissue, tamoxifen acts like estrogen on the uterus and has been linked to endometrial proliferation, polyps, and endometriosis.11PubMed Central. Bilateral ovarian endometriomas after laparoscopic hysterectomy following adjuvant tamoxifen therapy for breast cancer A 70-year-old woman taking tamoxifen for breast cancer would have a plausible hormonal explanation for new or recurrent endometriosis, even years after menopause.
The Diagnostic Blind Spot
Endometriosis in older women faces what researchers have described as a double disadvantage: ageist assumptions that the disease cannot exist after menopause, and longstanding biases around how seriously women’s pain is taken in medical settings. These factors combine to create prolonged diagnostic delays and frequent misattribution of symptoms to other conditions.12PubMed Central. Endometriosis in later life: an intersectional analysis from the perspective of epistemic injustice
Even when endometriosis is considered, imaging interpretation can be tricky. Pelvic ultrasound using a dedicated protocol is a reasonable first-line screening tool, particularly for detecting bowel-invasive disease. MRI offers better anatomic detail and the ability to evaluate both pelvic and extra-pelvic lesions at once, which is important because postmenopausal cases occasionally involve unusual locations beyond the pelvis.5PubMed. Postmenopausal Endometriosis: Clinical Insights and Imaging Considerations But any mass or lesion found in a postmenopausal woman will rightly raise concern for malignancy, and distinguishing a benign endometriotic cyst from ovarian cancer on imaging alone is not always straightforward. Tissue sampling may be necessary to settle the question.
The Malignant Transformation Question
One of the most serious concerns specific to postmenopausal endometriosis is the risk of the tissue turning cancerous. Malignant transformation of endometriosis is rare at any age, but the risk appears to be higher in older women, and particularly in those on estrogen-only HRT. When transformation does occur, the two most common types of cancer arising from endometriotic tissue are endometrioid adenocarcinoma and clear cell carcinoma, which together account for roughly 70% of these cases.13PubMed Central. Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature
This does not mean that most women with postmenopausal endometriosis will develop cancer. The vast majority will not. But the possibility is a legitimate reason why clinicians monitoring a postmenopausal woman with known endometriosis may recommend periodic imaging, and why any change in symptoms, rapid growth of a cyst, or new solid component on imaging warrants prompt evaluation. MRI is especially useful in this context because it can characterize features suggestive of malignant change within endometriotic lesions.
Endometriosis in Unusual Locations
Endometriosis occurring outside the pelvis is uncommon at any age, but postmenopausal cases have been reported in some surprisingly distant locations. The most frequently described extra-pelvic sites include the gastrointestinal tract, urinary system, retroperitoneum, abdominal wall, and even the thorax.14PubMed Central. Rare Clinical Presentation of Postmenopausal Endometriosis: A New Perspective These cases are rare enough that they are published individually as case reports, which tells you something about how infrequently they are encountered.
Extra-pelvic endometriosis in an older woman can mimic conditions ranging from inflammatory bowel disease to lung nodules, making correct diagnosis even more elusive than the pelvic form. A woman with cyclic chest pain before menopause might have been worked up for thoracic endometriosis, but a 70-year-old with a lung nodule is going to be investigated for cancer first and endometriosis perhaps never.
Treatment Options for Postmenopausal Endometriosis
Managing endometriosis after menopause is different from managing it during reproductive years, partly because many of the standard hormonal treatments used in younger women (oral contraceptives, GnRH agonists that suppress ovarian function) do not make sense when the ovaries are already inactive. Surgery to remove endometriotic lesions remains an option, but not every 70-year-old is a good surgical candidate, and not every case warrants an operation.
The most promising pharmacological approach targets the self-sustaining estrogen production described earlier. Aromatase inhibitors, drugs originally developed for breast cancer that block the conversion of other hormones to estrogen, have shown encouraging results in case reports and small series. They appear to reduce both symptoms and the size of endometriotic lesions in postmenopausal women.15PubMed Central. Aromatase inhibitors in post-menopausal endometriosis The logic is straightforward: if the implants are making their own estrogen via aromatase, blocking that enzyme should starve the tissue. One well-known case involved an aromatase inhibitor successfully treating an unusually aggressive recurrence in a postmenopausal woman.3PubMed. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis
Aromatase inhibitors do carry side effects, including accelerated bone loss (a particular concern in older women already at risk for osteoporosis) and joint pain. But for women who cannot or prefer not to have surgery, they represent the most targeted medical option currently available.16PubMed. Postmenopausal endometriosis: current evidence and clinical challenges in diagnosis and treatment The research base remains small, and no large randomized trial has been conducted specifically on aromatase inhibitors for postmenopausal endometriosis, so treatment decisions tend to be made case by case.
If a woman’s endometriosis was reactivated by HRT, stopping or changing the hormone regimen is an obvious first step. Switching from unopposed estrogen to a combined preparation, or discontinuing HRT altogether if the woman’s menopausal symptoms are manageable, can sometimes be enough to quiet the disease.10PubMed Central. Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature
Living With It After Menopause
Postmenopausal endometriosis affects more than the pelvis. Women dealing with ongoing or recurrent disease report significant effects on their quality of life, sexual health, and overall well-being.17PubMed. Postmenopausal endometriosis: a challenging condition beyond menopause These impacts can be compounded by the psychological burden of being told for years that their symptoms should not exist, or that menopause should have fixed everything.
There is also a practical frustration in navigating a medical system that is not well set up to recognize the condition in this age group. Gynecologists may not think to evaluate an older woman for endometriosis. General practitioners may attribute pelvic pain to musculoskeletal causes or gastrointestinal disorders. The result can be years of bouncing between specialists, a pattern that echoes the famously long diagnostic delays younger women with endometriosis already face, overlaid with additional age-related dismissiveness.12PubMed Central. Endometriosis in later life: an intersectional analysis from the perspective of epistemic injustice
What a 70-Year-Old Should Know
If you are in your 60s or 70s and experiencing unexplained pelvic pain, painful bowel movements, or other symptoms that feel like they could be gynecological in origin, endometriosis deserves a place on the list of possibilities, especially if you have a history of the disease, have taken HRT, or have used tamoxifen. You do not need to be menstruating for the condition to be active. The tissue can produce its own estrogen supply independent of your ovaries.
A history of endometriosis before menopause does not guarantee recurrence, and the absence of a prior diagnosis does not guarantee protection. Some postmenopausal cases arise in women who were never diagnosed earlier. Others reflect reactivation of disease that had been dormant for years or even decades. Either way, the condition is real, it is documented, and it has treatment options, even if those options are less well-studied than what is available to younger patients. The biggest barrier for most older women is not the disease itself but getting it recognized in the first place.